Patents by Inventor Eric Finzi

Eric Finzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING BOTULINUM TOXIN A
    Publication number: 20220339268
    Abstract: Methods are disclosed for treating post traumatic stress disorder (PTSD) in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilli and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilli and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Application
    Filed: July 12, 2022
    Publication date: October 27, 2022
    Inventors: Eric Finzi, Norman E. Rosenthal
  • Treatment of panic disorder using botulinum toxin
    Patent number: 11452766
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilii and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilii and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: September 27, 2022
    Inventors: Eric Finzi, Norman E. Rosenthal
  • Treatment of post-traumatic stress disorder using botulinum toxin A
    Patent number: 11419922
    Abstract: Methods are disclosed for treating post traumatic stress disorder (PTSD) in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilii and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilii and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: August 23, 2022
    Inventors: Eric Finzi, Norman E. Rosenthal
  • TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN
    Publication number: 20210046167
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilii and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilii and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Inventors: Eric Finzi, Norman E. Rosenthal
  • METHOD OF TREATING DEPRESSION
    Publication number: 20200384091
    Abstract: Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.
    Type: Application
    Filed: August 24, 2020
    Publication date: December 10, 2020
    Inventor: Eric Finzi
  • Treatment of social anxiety disorder, obsessive compulsive disorder and panic disorder using botulinum toxin
    Patent number: 10828348
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilii and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilii and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: November 10, 2020
    Assignee: Maryland Mental Health Institute, LLC
    Inventors: Eric Finzi, Norman E. Rosenthal
  • Method of treating depression
    Patent number: 10751395
    Abstract: Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: August 25, 2020
    Assignee: Maryland Mental Health Institute, LLC
    Inventor: Eric Finzi
  • TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN
    Publication number: 20190365873
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilii and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilii and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Application
    Filed: December 26, 2018
    Publication date: December 5, 2019
    Inventors: Eric Finzi, Norman E. Rosenthal
  • METHOD OF TREATING DEPRESSION
    Publication number: 20180236050
    Abstract: Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.
    Type: Application
    Filed: April 19, 2018
    Publication date: August 23, 2018
    Inventor: Eric Finzi
  • Method of treating depression
    Patent number: 9950045
    Abstract: Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: April 24, 2018
    Inventor: Eric Finzi
  • TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN
    Publication number: 20180043000
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilii and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilii and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Application
    Filed: October 4, 2017
    Publication date: February 15, 2018
    Inventors: Eric Finzi, Norman E. Rosenthal
  • Treatment of social anxiety disorder using botulinum toxin
    Patent number: 9808515
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilli and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilli and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: November 7, 2017
    Inventors: Eric Finzi, Norman E. Rosenthal
  • METHOD OF TREATING SEASONAL AFFECTIVE DISORDER
    Publication number: 20170258879
    Abstract: Methods are provided for treating or preventing seasonal affective disorder caused by the onset of a specific season in a subject. The method include administering a therapeutically effective amount of a neurotoxin to a facial muscle to cause paralysis of the facial muscle, thereby affecting the ability of the subject to frown and thus treating or preventing the seasonal affective disorder prior to the onset of the season.
    Type: Application
    Filed: March 9, 2017
    Publication date: September 14, 2017
    Inventors: Eric Finzi, Norman E. Rosenthal
  • METHOD OF TREATING DEPRESSION
    Publication number: 20170100465
    Abstract: Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 13, 2017
    Inventor: Eric Finzi
  • TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN
    Publication number: 20170014493
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilli and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilli and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Application
    Filed: September 27, 2016
    Publication date: January 19, 2017
    Inventors: Eric Finzi, Norman E. Rosenthal
  • Method of treating depression
    Patent number: 9533029
    Abstract: Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: January 3, 2017
    Inventor: Eric Finzi
  • TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING BOTULINUM TOXIN A
    Publication number: 20160256531
    Abstract: Methods are disclosed for treating post traumatic stress disorder (PTSD) in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilli and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilli and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Application
    Filed: November 15, 2013
    Publication date: September 8, 2016
    Inventors: Eric Finzi, Norman E. Rosenthal
  • TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN
    Publication number: 20160114015
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilli and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilli and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Application
    Filed: December 30, 2015
    Publication date: April 28, 2016
    Inventors: Eric Finzi, Norman E. Rosenthal
  • Treatment of social anxiety disorder, obsessive compulsive disorder and panic disorder using botulinum toxin
    Patent number: 9254314
    Abstract: Methods are disclosed for treating social anxiety disorder, obsessive compulsive disorder, and/or panic disorder in a subject. The methods include administering a therapeutically effective amount of a neurotoxin to a corrugator supercilli and/or a procerus muscle of the subject to cause paralysis of the corrugator supercilli and/or a procerus muscle in the subject, thereby treating PTSD. The neurotoxin can be Botulinum toxin A, such as at a dose of about 20 to about 50 units of Botulinum toxin A.
    Type: Grant
    Filed: November 11, 2014
    Date of Patent: February 9, 2016
    Inventors: Eric Finzi, Norman E. Rosenthal
  • METHOD OF TREATING DEPRESSION
    Publication number: 20150290302
    Abstract: Methods are disclosed herein for treating depression in the subject. A method includes the use of Botulinum toxin to cause paralysis of a facial muscle, such as the depressor anguli oris, procerus, frontalis, orbicularis oculi, or corrugator supercilii muscle to treat depression in the subject.
    Type: Application
    Filed: June 22, 2015
    Publication date: October 15, 2015
    Inventor: Eric Finzi